Tag: JAYseq
-
New TGen Clinical Test for Multiple Myeloma Consolidates Multiple Analyses and Provides Detailed Information in 3 Days
JAYseq, a powerful new whole genome sequencing assay delivers a comprehensive, 72 hour molecular profile to help oncologists personalize care for patients across the myeloma disease spectrum The Translational Genomics Research Institute (TGen), part of City of Hope, today announced the launch of JAYseq™, a clinical whole-genome sequencing (WGS) test specifically for multiple myeloma. Approximately 35,000 new…
